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Propionate is a short chain fatty acid that is abundant as butyrate in the gut and blood.
However, propionate has not been studied as extensively as butyrate in the treatment
of colitis. The present study was to investigate the effects of sodium propionate on
intestinal barrier function, inflammation and oxidative stress in dextran sulfate sodium
(DSS)-induced colitis mice. Animals in DSS group received drinking water from 1 to
6 days and DSS [3% (w/v) dissolved in double distilled water] instead of drinking water
from 7 to 14 days. Animals in DSS+propionate (DSS+Prop) group were given 1%
sodium propionate for 14 consecutive days and supplemented with 3% DSS solution on
day 7–14. Intestinal barrier function, proinflammatory factors, oxidative stress, and signal
transducer and activator of transcription 3 (STAT3) signaling pathway in the colon were
determined. It was found that sodium propionate ameliorated body weight loss, colon-
length shortening and colonic damage in colitis mice. Sodium propionate significantly
inhibited the increase of FITC-dextran in serum and the decrease of zonula occludens-1
(ZO-1), occludin, and E-cadherin expression in the colonic tissue. It also inhibited the
expression of interleukin (IL)-1β, IL-6, and tumor necrosis factor-α (TNF-α) mRNA and
phosphorylation of STAT3 in colitis mice markedly, reduced the myeloperoxidase (MPO)
level, and increased the superoxide dismutase and catalase level in colon and serum
compared with DSS group. Sodium propionate inhibited macrophages with CD68
marker infiltration into the colonic mucosa of colitis mice. These results suggest that
oral administration of sodium propionate could ameliorate DSS-induced colitis mainly
by improving intestinal barrier function and reducing inflammation and oxidative stress
via the STAT3 signaling pathway.
Keywords: ulcerative colitis, short-chain fatty acid, propionate, intestinal barrier function, tight junction protein,
inflammation, dextran sulfate sodium
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INTRODUCTION
Inflammatory bowel disease (IBD), including Crohn’s disease
and ulcerative colitis, is a group of chronic inflammatory
disorders of the gastrointestinal tract characterized by intestinal
inflammation and mucosal damage (Quetglas et al., 2015). It is
commonly believed that intestinal barrier function destruction,
intestinal flora disturbance, and immune dysfunction play
important roles in the pathogenesis of IBD (Quetglas et al., 2015;
Loddo and Romano, 2015). Glucocorticoids, sulfasalazine, and
immunosuppressive drugs have been traditionally used for the
treatment and maintenance of ulcerative colitis. However, clinical
application of these drugs is limited by their adverse effects (Mao
and Hu, 2016), and therefore there is an urgent need to seek
alternative remedies.
Increasing the intake of fermentable dietary fibers or short-
chain fatty acids (SCFAs) seems to be clinically beneficial to
the treatment of colitis (Cabre and Domenech, 2012). SCFAs,
predominantly acetate, propionate, and butyrate, are produced
in the colonic lumen by anaerobic fermentation of undigested
carbohydrates, crude fibers, and polysaccharides (Bolognini et al.,
2016). Depending on diet and gut microbiota composition, the
intestinal SCFA concentration can range from 60 to 150 mmol/L
(Hill, 1995), with butyrate, propionate, and acetate in a nearly
constant molar ratio of 15:25:60, respectively (D’Argenio and
Mazzacca, 1999). The physiological effects of SCFAs have been
well documented, which include reducing the production of
proinflammatory factors (Huang and Wu, 1997; Meijer et al.,
2010), enhancing intestinal barrier function (Mariadason et al.,
1997, 1999; Peng et al., 2007; Suzuki et al., 2008; Van Deun et al.,
2008; Elamin et al., 2013), inhibiting oxidative stress (Hamer
et al., 2009, 2010), and preventing colon carcinogenesis (Clausen
et al., 1991; Hijova and Chmelarova, 2007) in vitro, in vivo,
and in animals. However, most previous studies mainly focused
on butyrate, and few studies have devoted their efforts to other
SCFAs such as propionate, although it is abundant as butyrate in
the gut and blood.
The aim of the present study was to investigate the effects
of sodium propionate on intestinal barrier function and the
expression of tight junction protein in mice with colitis induced
by dextran sulfate sodium (DSS). In addition, the effects of
sodium propionate on inflammation and oxidative stress and
signal transducer and activator of transcription 3 (STAT3)
signaling pathway were also investigated.
MATERIALS AND METHODS
Materials
The main materials used in this study were DSS (molecular
weight 36–50 kDa, MP Biomedicals, Inc., Aurora, OH, USA);
sodium propionate (Sinopharm Chemical Reagent CO., Ltd.,
Shanghai, China); Trizol reagent (Invitrogen, Carlsbad, CA,
USA); PrimeScript RT Master Mix Perfect Real Time kit
(Takara Biotechnology, Dalian, China); FastStart Universal SYBR
Green Master (Rox; Roche, Mannheim, Germany); superoxide
dismutase (SOD), myeloperoxidase (MPO), and catalase (CAT)
kit (Jiancheng, Nanjing, China).
The main reagents used in this study were antibodies for
E-cadherin and occluding (Cell Signaling Technology, Danvers,
MA, USA; Life Technologies Inc., Gaithersburg, MD, USA);
zonula occludens-1 (ZO-1) antibody and β-actin (Santa Cruz
Biotechnology, Inc., Santa Cruz, CA, USA; Sigma–Aldrich,
St. Louis, MO, USA); mouse anti-CD68 monoclonal antibody
(Abcam, Cambridge, England); mouse anti-STAT-3 monoclonal
(124H6) and anti-p-STAT-3 (Tyr705) antibodies (Cell Signaling
Technology, Danvers, MA, USA).
Animals
C57BL/6J male mice weighing 18–22 g were obtained from SLRC
Laboratory Animal Lid (Shanghai, China). All mice were kept
under an automated 12 h/12 h dark-light cycle at a controlled
temperature of 22◦C ± 2◦C, relative humidity of 50–60% and
allowed free access to standard dry diet and tap water ad libitum.
All animals received humane care, and experimental procedures
were performed in accordance with the guidelines of the Second
Military Medical University for health and care of experimental
animals.
Dextran Sodium Sulfate-Induced Colitis
Forty mice were equally randomized to four groups: a control
group, a propionate group, a DSS group, and a DSS+propionate
(DSS+Prop) group. Mice in control and propionate groups
received drinking water and sodium propionate [1% (w/v)
dissolved in double distilled water], respectively, for 14
consecutive days. Mice in DSS group received drinking water
from 1 to 6 days and DSS [3% (w/v) dissolved in double distilled
water] instead of drinking water from 7 to 14 days. Mice in
DSS+prop group received sodium propionate [1% (w/v)] from
1 to 6 days plus DSS [1% (w/v)] from 7 to 14 days. The disease
activity index including weight loss, stool consistency, and fecal
blood was evaluated every day. At day 15, all animals were
sacrificed by dislocation of the cervical vertebra for blood and
organ collection.
Histopathological Assessment
All mice were sacrificed for histological assessment. The colon
length was first measured for each group, and then the
colon was cut into segments for further detection. Colons
in the same position were fixed in 4% neutral formalin,
paraffin embedded, and HE stained routinely. Histopathological
changes were evaluated by using the histological injury scale
as described previously (Wirtz et al., 2007). The criteria
for evaluation were as follows: 0: no obvious inflammatory
reaction; 1: the presence of low-level inflammatory reaction
with a few scattered inflammatory cells; 2: the presence of
moderate inflammatory infiltration; 3: the presence of severe
inflammatory reaction in the colon tissue as represented by
increased vascular density and thickness; 4: the presence of large
amounts of inflammation cell infiltration and rupture of goblet
cell mass.
In vivo Intestinal Permeability
The in vivo intestinal epithelial permeability was determined as
described previously (Moussaoui et al., 2014). Briefly, mice were
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fasted overnight and FITC-dextran solution (4 kDa, 600 mg/kg)
was delivered via gavage. Mice were sacrificed at 4 h after
intragastric administration, and blood was harvested via cardiac
puncture and then separated by centrifugation. Serum levels
of FITC were read at 480 and 520 nm on a microplate
fluorometer.
Protein Extraction and Immunoblotting
Analysis
Immunoblotting was performed as described previously (Zhang
et al., 2011). Briefly, the colon tissue was sliced into sections
and washed with PBS. Tissue proteins were extracted by lysing
in RIPA buffer containing protease and phosphatase inhibitor
cocktail. The mixture was centrifuged at 14,000 × g and
4◦C for 15 min, and the protein content in the supernatant
was determined by Bradford method. An equal amount of
protein was separated by 10% (w/v) sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) and transferred
to nitrocellulose membranes. The membranes were blocked
for 3 h at room temperature with blocking reagent, and
the primary antibodies were incubated overnight at 4◦C.
The antibodies included anti-ZO-1 (1:1000), anti-E-cadherin
(1:1000), anti-occludin antibody (1:2000), anti-STAT3 (1:1000),
anti-p-STAT3 (1:1000), and anti-β-actin antibody (1:5000).
After washing with PBST, the membranes were incubated
with corresponding secondary antibodies (1:10000 dilution) for
50 min at room temperature. Specific bands were scanned and
analyzed by Odyssey Infrared Imaging System (LI-COR, Lincoln,
NE, USA). β-actin was used as the protein loading control.
All immunoblotting experiments were repeated at least three
times.
RNA Isolation and Quantitative RT-PCR
Total RNA was extracted from the colon tissue in each group
with Trizol reagent according to the manufacturer’s instructions.
After reverse transcription, complementary DNA was used as
templates for PCR. Primers for the inflammatory factors and
internal reference were as follows: tumor necrosis factor-α
(TNF-α): forward, 5′-CATTTCCACG ATTTCCCAGA-3′, reve-
rse, 5′-GGAAAGCCCATTTGAGTCCT-3′; interleukin (IL)-1β:
forward, 5′-CTCACAAGCAGAGCACAAGC-3′, reverse, 5′-CA
GTCCAGCCCATA CTTTAGG-3′; IL-6: forward, 5′-CGGAG
AGGAGACTTCACAGAG-3′, reverse, 5′-CATTTCCACGATTT
CCCAGA-3′; GAPDH: forward, 5′-GTATGACTCCACTC ACG
GCAAA-3′, reverse, 5′-GGTCTCGCTCCTGGAAGATG-3′.
The housekeeping gene GAPDH was used as internal control,
and the amount of RNA was calculated by the comparative
threshold cycle method as recommended by the manufacturer.
Quantitative real-time PCR was carried out by ABI 7500
real-time PCR system (Applied Biosystems, Foster, CA,
USA).
Measurement of Myeloperoxidase (MPO)
Level in Colon and Serum
The ability of MPO to modulate the hydrogen peroxide level
was used to measure MPO activity by using a modified method
according to the manufacturer’s instructions. The freshly excised
colon was rinsed, homogenized in tissue lysis buffer, and
then centrifuged. Pellets were re-suspended in PBS containing
0.5% hexadecyl-trimethylammonium bromide and then freeze-
thawed three times. Absorbance was recorded at 460 nm.
The protein concentration was determined using the BCA-
100 Protein Determination Kit (Bocai Biotechnology, Shanghai,
China). Finally, MPO activity was defined as the quantity of
enzyme degrading 1 µmol/ml of peroxide at 37◦C, expressed in
unit/mg protein.
Detection of CAT and SOD Level in Colon
and Serum
The freshly excised colon was rinsed, homogenized in tissue
lysis buffer, and then centrifuged. CAT and SOD activities in
tissue lysate and serum were measured by using the CAT or
SOD kit according to the manufacturer’s instruction (Nanjing
Jiancheng Bioengineering Institute, Nanjing, China). Using a
microplate fluorometer, CAT and SOD activities were measured
at 405 and 450 nm, respectively. The protein concentration was
measured by Bradford method. The concentration of CAT and
SOD in colon was presented as picograms per milligram colon
protein.
Assessment of Macrophages in Colonic
Mucosa by Immunofluorescence
Immunofluorescence was performed as described previously (Liu
et al., 2015). The 5 µm paraffin-embedded colonic tissue sections
were de-paraffinized in xylene and then rehydrated in ethanol
solution. The slides were blocked with 5% BSA in TBS for 90 min.
The sections were incubated with anti-CD68 antibody at a
dilution of 1:100 overnight at 4◦C. After the sections were washed
three times with TBS, the slides were incubated with Alexa Fluor
488 secondary antibody diluted 1:200 with TBS and incubated in
the dark for 120 min at room temperature. The sections were
mounted with mounting medium containing 4,6-diamidino-
2-phenylindole (DAPI; Beyotime Institute of Biotechnology,
Shanghai, China) for nuclear counterstaining and visualized
under a fluorescent microscope (Olympus IX71, Tokyo, Japan).
Macrophages were counted per square millimeter (mm2) at a
magnification of 400× using a grid ocular. Only cells containing
a nucleus stained by DAPI were considered. Counting was
performed by two observers independently who were blind
to the diagnosis of the specimen. The difference of their
results was never greater than 10%, and the mean value was
used.
Statistical Analysis
All quantified data were expressed as means ± SD. Data
involving more than two groups were assessed by analysis
of variance (ANOVA). Values of P < 0.05 were considered
statistically significant. Statistical analysis was performed using
SPSS (Version 18.0 for Windows, SPSS Inc., Chicago, IL,
USA).
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RESULTS
Effects of Sodium Propionate on Body
Weight, Colon Length, and
Histopathology in DSS-Induced Colitis
Mice
There was no significant difference in body weight, colon length,
histological evaluation, and histological score between control
and propionate groups.
Compared with control group, mice treated with DSS showed
body weight loss on day 13 and day 14 (Figure 1A). However,
the administration of sodium propionate significantly improved
the body weight loss on day 13 and day 14 as compared with
DSS group (19.56 ± 1.43 vs. 16.40 ± 0.44, 18.06 ± 1.40 vs.
15.14± 0.50, respectively; Figure 1A).
Compared with control group, the colon length was
significantly shortened in DSS-induced mice.
Compared with DSS group, the administration of sodium
propionate significantly increased the colonic length (6.70± 0.62
vs. 5.64± 0.48, respectively; Figure 1C).
Dextran sulfate sodium-induced mice presented more serious
intestinal bleeding than mice in control group.
Compared with DSS group, sodium propionate ameliorated
the intestinal bleeding (1.20 ± 0.84 vs. 2.80 ± 0.45, respectively;
Figure 1B).
FIGURE 1 | Effects of sodium propionate on body weight, bloody score, colon length, and histopathology in DSS-induced colitis mice. Mice were
divided into four groups. Animals in control and propionate groups received water and sodium propionate [1% (w/v) dissolved in water] alone, respectively, during the
14-day treatment period. Animals in DSS group received drinking water from 1 to 6 days and DSS [3% (w/v) dissolved in double distilled water] instead of drinking
water from 7 to 14 days. Animals in DSS+propionate (DSS+Prop) group were given 1% sodium propionate for 14 consecutive days and supplemented with 3%
DSS solution on day 7–14. Body weight (A), bloody score (B), and colon length (C) were examined. HE stained colon tissue sections were analyzed for
histopathology (D). Images were representative of 6–8 mice. Colon injury scores were also determined (E). Scar bars were 100 and 50 µm, respectively. Data are
presented as mean ± SD, n = 10 per group. ∗P < 0.05, ∗∗P < 0.01 vs. control group; #P < 0.05, ##P < 0.01 vs. DSS group.
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The histological and morphological characteristics of the
colon were assessed by HE staining. The colon from control
group showed intact morphology and substantial goblet cells.
However, the colon from DSS group presented serious ulcers
in the colon membrane, and the number of goblet cells was
decreased obviously, causing a high histological score. Compared
with DSS group, sodium propionate ameliorated the intestinal
ulcer, and blocked neutrophil cell infiltration with minimal loss
of goblet cells, resulting in a low histological damage score
(2.20 ± 0.84 vs. 3.80 ± 0.45, respectively; Figures 1D,E). These
results suggest that sodium propionate could ameliorate tissue
injury induced by DSS.
Sodium Propionate Improves Intestinal
Barrier Function in DSS-Induced Colitis
Mice
Intestinal barrier function plays an important role in maintaining
normal bowel function by preventing harmful substances such
as intestinal bacteria and toxins from going into other tissues or
blood circulation via the intestinal mucosa. The destruction of the
intestinal barrier function would lead to colitis and even systemic
inflammatory response syndrome (Colgan et al., 2015). There
was no significant difference in serum FITC-dextran and the
expression of tight junction associated proteins between control
and propionate groups. Serum FITC-dextran in DSS-induced
colitis mice was higher than that in control mice. However,
sodium propionate significantly inhibited the increase of FITC-
dextran in serum (0.93 ± 0.02 vs. 1.25 ± 0.07, respectively;
Figure 2A). Compared with control group, the expression of tight
junction associated proteins including ZO-1, E-cadherin, and
occludin, was decreased in DSS-induced colitis mice, indicating
that intestinal barrier function was damaged seriously. Compared
with DSS group, sodium propionate significantly increased the
level of TJ associated proteins include ZO-1 (0.97 ± 0.11 vs.
0.49± 0.07, respectively), E-cadherin (1.03± 0.10 vs. 0.57± 0.05,
respectively) and occludin (1.07 ± 0.18 vs. 0.61 ± 0.08,
respectively; Figures 2B–E), indicating that sodium propionate
might contribute to the protection of intestinal barrier function.
Sodium Propionate Attenuates the Trend
of Increased Expression of
Proinflammatory Factor mRNA and
Inhibits the Activation of STAT3 Signaling
Pathway
There was no significant difference in mRNA expression level
of proinflammatory factors and STAT3 between control and
propionate groups.
Compared with control mice, the mRNA expression levels
of proinflammatory factors such as TNF-α, IL-1β, and IL-6
were increased markedly. Compared with DSS group, sodium
propionate significantly inhibited the expression of TNF-α
(2.15 ± 0.25 vs. 3.43 ± 0.96, respectively), IL-1β (3.15 ± 0.69 vs.
5.50 ± 0.60, respectively), and IL-6 (1.77 ± 1.09 vs. 3.62 ± 0.84,
respectively; Figures 3A–C).
Compared with control group, the phosphorylation level of
STAT3 was increased in DSS-induced colitis mice. However,
sodium propionate significantly inhibited the phosphorylation
of STAT3 and decreased inflammatory reaction accordingly
(1.00± 0.05 vs. 4.96± 0.59, respectively; Figure 3D).
Sodium Propionate Inhibits Oxidative
Stress in DSS-Induced Colitis Mice
Oxidative stress is considered an important factor in colitis in that
it can induce the expression of oxygen free radical and lead to fat,
protein, and DNA damage (Balmus et al., 2016). MPO, known as
a promoting agent for oxidative stress, was significantly increased
in serum and colonic tissue in DSS-induced mice compared with
control mice. Sodium propionate decreased the level of MPO
in colon (8.69 ± 4.30 vs. 15.61 ± 3.45, respectively) and serum
(0.25 ± 0.05 vs. 0.40 ± 0.07, respectively) compared with DSS
group (Figures 4A,B).
Accordingly, the levels of anti-oxidative stress factors
including SOD and CAT in serum and colon were significantly
decreased in DSS-induced mice compared with the control.
Compared with DSS group, sodium propionate increased the
level of SOD in colon (8.13 ± 1.56 vs. 6.05 ± 0.46, respectively)
and in serum (0.35 ± 0.03 vs. 0.26 ± 0.04, respectively);
meantime, sodium propionate increased the level of CAT in
colon (7.33 ± 1.16 vs. 5.27 ± 1.16, respectively) and in serum
(0.41 ± 0.06 vs. 0.31 ± 0.10, respectively) (Figures 4C–F). There
was no significant difference in serum and colon levels of MPO,
SOD, and CAT between control and propionate groups.
Sodium Propionate Inhibits Expression
of CD68 in DSS-Induced Colitis Mice
Destruction of the intestinal barrier can lead to macrophage
infiltration into the colon, which can exacerbate the
inflammatory process. Expression of CD68 serves as a marker of
macrophages/monocytes in the colon. There was no significant
difference in CD68 expression between control and propionate
groups. The expression of CD68 was significantly increased
in DSS-induced mice compared with the control. However,
sodium propionate reduced the expression of CD68 in the colon
compared with DSS-induced colitis mice. Quantification of CD68
positive macrophages also showed same result (84.33 ± 13.05 vs.
180.67± 16.65, respectively; Figure 5).
DISCUSSION
In the present study, we found that sodium propionate inhibited
the down-regulation of tight junction proteins such as ZO-1,
occludin, and E-cadherin, and improved the impaired intestinal
barrier function induced by DSS. Sodium propionate also
reduced the expression of pro-inflammatory factors TNF-α,
IL-1β, and IL-6 mRNA in colon tissues. Moreover, sodium
propionate inhibited oxidative stress in the colon by reducing
MPO activity and enhancing SOD and CAT activities in serum
and colon.
Intestinal epithelial barrier defects have been recognized as
an important pathogenic factor in a number of inflammatory
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FIGURE 2 | The effects of sodium propionate on intestinal barrier function in DSS-induced mice. The FITC-dextran levels in serum were determined (A).
n = 10 per group. The expression of tight junction and associated protein ZO-1, E-cadherin and occluding in colonic tissues was determined by immunoblotting
(B–E). β-actin was used as the protein loading control. n = 4 per group. Representative blots of three independent experiments are shown. Data are presented as
mean ± SD. ∗P < 0.05, ∗∗P < 0.01 vs. control group; #P < 0.05, ##P < 0.01 vs. DSS group.
FIGURE 3 | The effects of sodium propionate on the expression of proinflammatory factor mRNA and STAT3 phosphorylation in colitis mice. The
expression level of proinflammatory factor mRNA was detected by real-time PCR. The mRNA level in each group was determined by relating to the level in control
group (defined as 100%; A–C). STAT3 expression in the colon was determined by immunoblotting (D). β-actin was used as the protein loading control. n = 4 per
group. Representative blots of three independent experiments are shown. ∗P < 0.05, ∗∗P < 0.01 vs. control group; #P < 0.05, ##P < 0.01 vs. DSS group.
conditions of the gut, including CD and UC (Sánchez de Medina
et al., 2014). Intestinal epithelial barrier defects are characterized
by increased intestinal permeability. Tight junctions and
adherence junctions mainly restrict and modulate intestinal
permeability (Lee, 2015). In this study, we chose occludin and
E-cadherin as the representative proteins of tight junctions
and adherence junctions, and used ZO-1 as the representative
protein of connecting transmembrane proteins to cytoskeleton
proteins. It was found that sodium propionate increased the
serum FITC-dextran level and inhibited the down-regulation of
tight junctions and its associated protein occludin, E-cadherin,
and ZO-1 in the colon of colitis mice. A recent study showed
that multi-fiber mix feeding increased the concentration of total
SCFA, acetate, propionate and butyrate in the caecum and
epithelial expression and correct localization of tight junction
proteins (occludin and ZO-1) in IL-10−/− mice (Wang et al.,
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FIGURE 4 | The effects of sodium propionate on oxidative stress response in colitis mice. MPO, SOD, and CAT levels in colonic tissues were determined
(A,C,E). MPO, SOD, and CAT levels in serum were shown (B,D,F). Data are presented as mean ± SD. n = 10 per group, ∗P < 0.05, ∗∗P < 0.01 vs. control group;
#P < 0.05, ##P < 0.01 vs. DSS group.
2016). A more previous study also showed that the amount
of dietary fiber significantly altered the barrier function by
reducing paracellular permeability in the distal colon of normal
rats (Mariadason et al., 1999). It was found that applying the
SCFA mixture to the intestinal mucosa of anesthetized rats
suppressed [3H] mannitol transport from the caecal lumen
to the mesenteric blood in a dose-dependent manner, while
propionate alone dose-dependently increased transepithelial
electrical resistance in T84 and Caco-2 cells (Mariadason et al.,
1997; Suzuki et al., 2008). Elamin et al. (2013) also reported
that pretreatment of Caco-2 cells with 4 mmol/L propionate
significantly alleviated the ethanol-induced barrier dysfunction,
tight junction and F-actin disruption, and metabolic stress.
Consistently, our results demonstrated that oral administration
of sodium propionate could restore intestinal barrier function,
at least in part, through inhibiting the down-regulation of tight
junction and its associated protein in colitis mice. It is believed
that sodium propionate cannot reach the colon due to its rapid
gastric and duodenal absorption. Therefore, to verify whether
oral sodium propionate could reach the colon, the concentration
of sodium propionate in the caecum content needs further
research.
Chronic inflammation as a hallmark of IBD often results
from the recruitment and activation of immune cells from the
circulation. It is postulated that intestinal tight junction barrier
defects allow for paracellular permeation of noxious luminal
antigens that induce inflammatory response. It was found
that propionate decreased the generation of proinflammatory
cytokines in a co-culture system combining Caco-2 cells with
human whole blood (Hamer et al., 2008). Propionate could also
diminish TNF-α production and release in neutrophils upon
stimulation by lipopolysaccharide (Tedelind et al., 2007; Vinolo
et al., 2011). These findings in vitro show that propionate has a
favorable effect on IBD by attenuating activation of macrophages
and neutrophils. The present study in vivo found that sodium
propionate inhibited the up-regulation of proinflammatory
factors IL-6, IL-1β, and TNF-α mRNA level in the colon of colitis
mice.
Additionally, proinflammatory factors activate macrophages
and neutrophils to infiltrate into the colonic mucosa, which in
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FIGURE 5 | The effects of sodium propionate on macrophages with
CD68 marker in the colonic tissue. Macrophages were determined by
immunofluorescence in colonic tissues. CD68 was used as the marker of
macrophage/monocyte infiltration in the colon of mice and visualized by
fluorescence microcopy (green staining). Nuclei were stained with DAPI (blue
staining). Arrows indicate CD68-labeled macrophages in the colon. Images
were representative of 6–8 mice in each group. Scar bars were 100 µm.
Morphometric analysis of macrophages in the colon was also performed. Data
are presented as mean ± SD. n = 6–8 per group, ∗P < 0.05, ∗∗P < 0.01 vs.
control group; #P < 0.05, ##P < 0.01 vs. DSS group.
turn stimulates the production of reactive oxygen species (ROS),
particularly superoxide, leading to oxidative stress (Roessner
et al., 2008). ROS and reactive nitrogen species (RNS) produced
by macrophages and neutrophils may further aggravate the
inflammatory response and cause intestinal mucosal damage
in IBD (Piechota-Polanczyk and Fichna, 2014). CD68 protein
is known as a cell surface glycoprotein expressed in mature
macrophages in the intestinal lamina propria and serves as
a marker of macrophage and monocyte infiltration into the
colon (Caprioli et al., 2013). We found that macrophages with
CD68 marker were increased in colonic mucosa, and sodium
propionate inhibited macrophage infiltration into the colonic
mucosa in DSS-induced mice. We also found that sodium
propionate decreased the MPO activity and increased the CAT
and SOD activities in colon and serum. Taken together, our
results indicate that sodium propionate alleviated inflammation
and oxidative stress by inhibiting macrophage infiltration into
the intestinal mucosa in DSS-induced colitis mice. However,
how sodium propionate decreases macrophage infiltration into
the intestinal mucosa and regulates macrophage function needs
further investigation.
It was demonstrated that the level of activated STAT3 was
higher in intestinal epithelial cells from patients with active
ulcerative colitis compared with that in patients with inactive
disease or healthy controls, and this level was positively correlated
with the severity of colitis (Nguyen et al., 2015). We found
that sodium propionate inhibited phosphorylation of STAT3
induced by colitis, which is consistent with the previous report
that multi-fiber mix feeding decreased p-STAT3 expression in
colonic mucosa of IL-10−/− mice (Wang et al., 2016). STAT3
is a transcriptional activator and activated by a variety of
cytokines, growth factors, and oxidative stress as well (Han
and Theiss, 2014). But how sodium propionate inhibits STAT3
phosphorylation in colitis needs further study.
Moreover, no in vivo toxicity was observed after oral
administration of 1% sodium propionate in this study,
confirming the safety of sodium propionate. Although the
colitis mice treated with propionate could not recover to normal,
it is worth noting that low-dose (1%) oral sodium propionate
attenuated acute DSS-induced colitis. It is important to avoid
overdosing sodium propionate in clinical practice, as it may
exacerbate rather than ameliorate colitis. Future studies are
needed to compare the efficacy and safety of low-dose vs.
high-dose sodium propionate oral therapy.
In summary, the present study demonstrated that oral
administration of sodium propionate exerted beneficial effects
on the intestinal epithelium by improving intestinal barrier
function, inhibiting inflammation, and modulating oxidative
stress through STAT3 signal pathway in DSS-induced colitis mice.
Our study not only provides in vivo evidence for but gains
preliminary mechanistic insights into the potential therapeutic
benefits of sodium propionate for the management of colitis.
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